Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Reaches New 12-Month High at $52.25

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF)’s share price reached a new 52-week high during trading on Tuesday . The stock traded as high as $52.25 and last traded at $52.25, with a volume of 0 shares traded. The stock had previously closed at $52.25.

Recordati Industria Chimica e Farmaceutica Price Performance

The firm has a market capitalization of $10.78 billion, a PE ratio of 18.80 and a beta of 0.33. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.95 and a current ratio of 1.36. The firm’s 50-day moving average is $52.15 and its 200 day moving average is $51.79.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $0.70 earnings per share for the quarter. The business had revenue of $622.00 million for the quarter. Recordati Industria Chimica e Farmaceutica had a net margin of 17.41% and a return on equity of 30.78%.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.